XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,292 | +13.4% | 359,838 | +18.8% | 0.12% | +30.0% |
Q1 2023 | $10,844 | -98.9% | 302,980 | +867.0% | 0.09% | +650.0% |
Q2 2022 | $953,000 | +426.5% | 31,332 | +164.0% | 0.01% | +500.0% |
Q3 2021 | $181,000 | -27.3% | 11,866 | -40.3% | 0.00% | -66.7% |
Q2 2020 | $249,000 | – | 19,888 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |